1. Home
  2. AMGN
  3. AMGN News

Latest Amgen Inc. (AMGN) News on February 23, 2025

4 Seniors & Aging Demographics Stocks to Watch Right Now
AMGN

Zacks

a day ago

4 Seniors & Aging Demographics Stocks to Watch Right Now

Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
AMGN

Zacks

2 days ago

Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock

There May Be Some Bright Spots In Amgen's (NASDAQ:AMGN) Earnings
AMGN

Simply Wall St.

2 days ago

There May Be Some Bright Spots In Amgen's (NASDAQ:AMGN) Earnings

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
AMGN

Zacks

3 days ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

AMGN

MT Newswires

3 days ago

Bernstein Adjusts Amgen Price Target to $350 From $380, Maintains Outperform Rating

AMGN

MT Newswires

3 days ago

Argus Cuts Price Target on Amgen to $330 From $360, Maintains Buy Rating

AMGN

Argus Research

3 days ago

Analyst Report: AMGEN Inc.

AMGN

Argus Research

3 days ago

Market Update: AMGN, KO, KR, KSS, ANET

Amgen Inc. (AMGN): A Bull Case Theory
AMGN

Insider Monkey

6 days ago

Amgen Inc. (AMGN): A Bull Case Theory

Amgen Full Year 2024 Earnings: EPS Misses Expectations
AMGN

Simply Wall St.

6 days ago

Amgen Full Year 2024 Earnings: EPS Misses Expectations

Amgen Inc. (AMGN): Among the Best Drug Stocks to Buy Now
AMGN

Insider Monkey

6 days ago

Amgen Inc. (AMGN): Among the Best Drug Stocks to Buy Now

AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT
AMGN

PR Newswire

8 days ago

AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT

Moderna's Q4 loss: Can the pharma giant get to profitability?
AMGN

Yahoo Finance Video

9 days ago

Moderna's Q4 loss: Can the pharma giant get to profitability?

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
AMGN

Zacks

9 days ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

AMGN

Argus Research

9 days ago

Daily – Vickers Top Buyers & Sellers for 02/14/2025

AMGN

MT Newswires

9 days ago

Amgen Insider Sold Shares Worth $2,585,644, According to a Recent SEC Filing

AMGN

MT Newswires

12 days ago

Amgen Insider Sold Shares Worth $7,341,123, According to a Recent SEC Filing

AMGN

MT Newswires

13 days ago

Piper Sandler Adjusts Amgen Price Target to $329 From $310, Maintains Overweight Rating

Is Trending Stock Amgen Inc. (AMGN) a Buy Now?
AMGN

Zacks

13 days ago

Is Trending Stock Amgen Inc. (AMGN) a Buy Now?

Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move
AMGN

Motley Fool

13 days ago

Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move

3 Fabulous Dividend Stocks to Buy in February
AMGN

Motley Fool

13 days ago

3 Fabulous Dividend Stocks to Buy in February

Don't Race Out To Buy Amgen Inc. (NASDAQ:AMGN) Just Because It's Going Ex-Dividend
AMGN

Simply Wall St.

14 days ago

Don't Race Out To Buy Amgen Inc. (NASDAQ:AMGN) Just Because It's Going Ex-Dividend

Amgen Inc. (AMGN): ‘Absurd That This Stock Sells for 14x Earnings’ – Jim Cramer on Blockbuster Drugs
AMGN

Insider Monkey

14 days ago

Amgen Inc. (AMGN): ‘Absurd That This Stock Sells for 14x Earnings’ – Jim Cramer on Blockbuster Drugs

AMGEN TO PRESENT AT THE 35th ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE
AMGN

PR Newswire

15 days ago

AMGEN TO PRESENT AT THE 35th ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE

Amgen Stock Has Surged. Here’s Where It’s Headed Next.
AMGN

Barrons.com

16 days ago

Amgen Stock Has Surged. Here’s Where It’s Headed Next.

AMGN

MT Newswires

16 days ago

Daiwa Securities Adjusts Amgen's Price Target to $350 From $360

Amgen (NASDAQ:AMGN) Has Announced That It Will Be Increasing Its Dividend To $2.38
AMGN

Simply Wall St.

17 days ago

Amgen (NASDAQ:AMGN) Has Announced That It Will Be Increasing Its Dividend To $2.38

The Zacks Analyst Blog Highlights Amgen, CRISPR, Moderna, Sarepta and Vertex
AMGN

Zacks

17 days ago

The Zacks Analyst Blog Highlights Amgen, CRISPR, Moderna, Sarepta and Vertex

Company News for Feb 6, 2025
AMGN

Zacks

17 days ago

Company News for Feb 6, 2025

AMGN

Morningstar Research

17 days ago

Analyst Report: Amgen Inc.

Amgen Shrugs Off A Surprise Setback For One Of Its Obesity Drugs
AMGN

Investor's Business Daily

17 days ago

Amgen Shrugs Off A Surprise Setback For One Of Its Obesity Drugs

Why Amgen (AMGN) Stock Is Trading Up Today
AMGN

StockStory

17 days ago

Why Amgen (AMGN) Stock Is Trading Up Today

Biotech Stock Roundup: REGN Up on Q4 Results, VRTX, AXSM Gain on Drug Approval
AMGN

Zacks

17 days ago

Biotech Stock Roundup: REGN Up on Q4 Results, VRTX, AXSM Gain on Drug Approval

AMGN's Q4 Earnings Beat, Obesity Candidate Under FDA Clinical Hold
AMGN

Zacks

17 days ago

AMGN's Q4 Earnings Beat, Obesity Candidate Under FDA Clinical Hold

AMGN

MT Newswires

18 days ago

Cantor Fitzgerald Adjusts Amgen's Price Target to $340 From $405

AMGN

MT Newswires

18 days ago

TD Cowen Adjusts Amgen's Price Target to $389 From $383

AMGN

Thomson Reuters StreetEvents

18 days ago

Q4 2024 Amgen Inc Earnings Call

AMGN

MT Newswires

18 days ago

RBC Trims Price Target on Amgen to $320 From $324, Keeps Outperform Rating

AMGN

MT Newswires

18 days ago

Morgan Stanley Lifts Price Target on Amgen to $328 From $322, Keeps Equalweight Rating

AMGN

Investing.com

18 days ago

Amgen stock slips on annual outlook; Q4 results top estimates

Amgen Inc (AMGN) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansions
AMGN

GuruFocus.com

18 days ago

Amgen Inc (AMGN) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansions

Amgen (AMGN) Q4 2024 Earnings Call Transcript
AMGN

Motley Fool

18 days ago

Amgen (AMGN) Q4 2024 Earnings Call Transcript

AMGN

MT Newswires

19 days ago

Deutsche Bank Adjusts Price Target on Amgen to $280 From $285

The Zacks Analyst Blog Highlights Merck, Pfizer, Eli Lilly, Amgen and Bristol Myers Squibb
AMGN

Zacks

19 days ago

The Zacks Analyst Blog Highlights Merck, Pfizer, Eli Lilly, Amgen and Bristol Myers Squibb

Dow Logs Best January Since 2019: 5 Best Stocks in the ETF
AMGN

Zacks

19 days ago

Dow Logs Best January Since 2019: 5 Best Stocks in the ETF

Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates?
AMGN

Zacks

20 days ago

Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates?

The Zacks Analyst Blog Highlights Amgen, Cencora, Humana and Ardent Health
AMGN

Zacks

20 days ago

The Zacks Analyst Blog Highlights Amgen, Cencora, Humana and Ardent Health

Is Amgen Inc. (AMGN) the Best Cancer Stock to Buy According to Hedge Funds?
AMGN

Insider Monkey

20 days ago

Is Amgen Inc. (AMGN) the Best Cancer Stock to Buy According to Hedge Funds?

AMGEN ANNOUNCES WEBCAST OF 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
AMGN

PR Newswire

22 days ago

AMGEN ANNOUNCES WEBCAST OF 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS

Curious about Amgen (AMGN) Q4 Performance? Explore Wall Street Estimates for Key Metrics
AMGN

Zacks

23 days ago

Curious about Amgen (AMGN) Q4 Performance? Explore Wall Street Estimates for Key Metrics

Is Amgen Inc. (AMGN) a Cheap Quarterly Dividend Stock to Invest In?
AMGN

Insider Monkey

23 days ago

Is Amgen Inc. (AMGN) a Cheap Quarterly Dividend Stock to Invest In?

Here's Why Amgen (AMGN) is a Strong Momentum Stock
AMGN

Zacks

24 days ago

Here's Why Amgen (AMGN) is a Strong Momentum Stock

Amgen Set to Report Q4 Earnings: Is a Beat in the Cards?
AMGN

Zacks

24 days ago

Amgen Set to Report Q4 Earnings: Is a Beat in the Cards?

Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth
AMGN

Zacks

25 days ago

Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth

Here's Why Amgen (AMGN) is a Strong Value Stock
AMGN

Zacks

25 days ago

Here's Why Amgen (AMGN) is a Strong Value Stock

AMGN

MT Newswires

25 days ago

BMO Capital Adjusts Price Target on Amgen to $346 From $362, Keeps Outperform Rating

Amgen (AMGN) Stock Dips While Market Gains: Key Facts
AMGN

Zacks

25 days ago

Amgen (AMGN) Stock Dips While Market Gains: Key Facts

Drugmakers Show Restraint on Price Increases in New Trump Era
AMGN

The Wall Street Journal

25 days ago

Drugmakers Show Restraint on Price Increases in New Trump Era

Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth
AMGN

Zacks

a month ago

Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth

AMGN

MT Newswires

a month ago

Citigroup Adjusts Price Target on Amgen to $295 From $310, Maintains Neutral Rating

AMGN

Morningstar Research

a month ago

Analyst Report: Amgen Inc.

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
AMGN

Zacks

a month ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Is Most-Watched Stock Amgen Inc. (AMGN) Worth Betting on Now?
AMGN

Zacks

a month ago

Is Most-Watched Stock Amgen Inc. (AMGN) Worth Betting on Now?

Amgen opens new drug substance facility in North Carolina, US
AMGN

Pharmaceutical Technology

a month ago

Amgen opens new drug substance facility in North Carolina, US

AMGN

MT Newswires

a month ago

Janux Therapeutics Promotes Zachariah McIver to Chief Medical Officer

Novo Nordisk Surges As Next-Gen Obesity Drug Outperforms
AMGN

Investor's Business Daily

a month ago

Novo Nordisk Surges As Next-Gen Obesity Drug Outperforms

Novo Nordisk Jumps On Experimental Weight-Loss Drug Trial Results
AMGN

Investor's Business Daily

a month ago

Novo Nordisk Jumps On Experimental Weight-Loss Drug Trial Results

Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing
AMGN

Zacks

a month ago

Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
AMGN

Zacks

a month ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Can the 8 Worst-Performing Dow Jones Stocks in 2024 Beat the S&P 500 in 2025?
AMGN

Motley Fool

a month ago

Can the 8 Worst-Performing Dow Jones Stocks in 2024 Beat the S&P 500 in 2025?

Amgen's Lumakras Gets FDA Nod for Expanded Use in Colorectal Cancer
AMGN

Zacks

a month ago

Amgen's Lumakras Gets FDA Nod for Expanded Use in Colorectal Cancer

Amgen Inc. (AMGN): A Bull Case Theory
AMGN

Insider Monkey

a month ago

Amgen Inc. (AMGN): A Bull Case Theory

FDA approves Amgen’s combo therapy for colorectal cancer
AMGN

Pharmaceutical Technology

a month ago

FDA approves Amgen’s combo therapy for colorectal cancer

Here’s Why Amgen Inc. (AMGN) Is Among the Highest Yielding Dividend Stocks In the Dow
AMGN

Insider Monkey

a month ago

Here’s Why Amgen Inc. (AMGN) Is Among the Highest Yielding Dividend Stocks In the Dow

Why Amgen Inc. (AMGN) Is One of the Best Cheap Stocks to Buy for 2025?
AMGN

Insider Monkey

a month ago

Why Amgen Inc. (AMGN) Is One of the Best Cheap Stocks to Buy for 2025?

Why Is Amgen Inc. (AMGN) Among Louis Navellier’s Top Long-term Stock Picks?
AMGN

Insider Monkey

a month ago

Why Is Amgen Inc. (AMGN) Among Louis Navellier’s Top Long-term Stock Picks?

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
AMGN

TipRanks

a month ago

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

Amgen (AMGN) Rises Yet Lags Behind Market: Some Facts Worth Knowing
AMGN

Zacks

a month ago

Amgen (AMGN) Rises Yet Lags Behind Market: Some Facts Worth Knowing

AMGN

MT Newswires

a month ago

Amgen Says Lumakras With Vectibix Approved by FDA for Metastatic Colorectal Cancer

FDA APPROVES LUMAKRAS® (SOTORASIB) IN COMBINATION WITH VECTIBIX® (PANITUMUMAB) FOR CHEMOREFRACTORY KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER
AMGN

PR Newswire

a month ago

FDA APPROVES LUMAKRAS® (SOTORASIB) IN COMBINATION WITH VECTIBIX® (PANITUMUMAB) FOR CHEMOREFRACTORY KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER

FDA Greenlights Amgen's New Cancer Drug Combo, Boosting Survival for KRAS G12C Patients
AMGN

GuruFocus.com

a month ago

FDA Greenlights Amgen's New Cancer Drug Combo, Boosting Survival for KRAS G12C Patients

Novo shares high-dose Wegovy results; Amgen, AstraZeneca drugs get expanded OKs
AMGN

BioPharma Dive

a month ago

Novo shares high-dose Wegovy results; Amgen, AstraZeneca drugs get expanded OKs

Is Amgen Inc. (AMGN) Among the Best NASDAQ Dividend Stocks to Buy?
AMGN

Insider Monkey

a month ago

Is Amgen Inc. (AMGN) Among the Best NASDAQ Dividend Stocks to Buy?

2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows
AMGN

Motley Fool

a month ago

2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows

NVO, VKTX Stocks Fall as Lilly's Zepbound, Mounjaro Sales Slow Down
AMGN

Zacks

a month ago

NVO, VKTX Stocks Fall as Lilly's Zepbound, Mounjaro Sales Slow Down

Amgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to Know
AMGN

Zacks

a month ago

Amgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to Know

JPM25: Amgen’s defense, Merck’s patent ‘hill’ and Viking’s long-term planning
AMGN

BioPharma Dive

a month ago

JPM25: Amgen’s defense, Merck’s patent ‘hill’ and Viking’s long-term planning

Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term
AMGN

Zacks

a month ago

Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
AMGN

Zacks

a month ago

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows.
AMGN

Motley Fool

a month ago

Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows.

JP Morgan 2025: reduced dosing and expanded manufacturing paving way for Amgen’s obesity entrance
AMGN

Clinical Trials Arena

a month ago

JP Morgan 2025: reduced dosing and expanded manufacturing paving way for Amgen’s obesity entrance

Why Amgen (AMGN) is a Top Value Stock for the Long-Term
AMGN

Zacks

a month ago

Why Amgen (AMGN) is a Top Value Stock for the Long-Term

3 High-Yield Dividend Stocks to Buy in 2025
AMGN

Motley Fool

a month ago

3 High-Yield Dividend Stocks to Buy in 2025

AMGN

MT Newswires

a month ago

Wells Fargo Cuts Price Target on Amgen to $280 From $335, Maintains Equalweight Rating

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
AMGN

Investor's Business Daily

a month ago

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.

Viking Therapeutics Starts Mid-Stage Study on Oral Weight-Loss Drug
AMGN

Zacks

a month ago

Viking Therapeutics Starts Mid-Stage Study on Oral Weight-Loss Drug

AMGEN TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
AMGN

PR Newswire

a month ago

AMGEN TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

AMGN

MT Newswires

a month ago

Goldman Sachs Adjusts Price Target on Amgen to $370 From $375, Maintains Buy Rating

AMGN

MT Newswires

a month ago

Truist Lowers Price Target on Amgen to $298 From $333, Keeps Hold Rating

Amgen (AMGN) Advances While Market Declines: Some Information for Investors
AMGN

Zacks

a month ago

Amgen (AMGN) Advances While Market Declines: Some Information for Investors

Share on Social Networks: